Current pathophysiologic approaches to heart failure;Approches physiopathologiques actuelles de l'insuffisance cardiaque

Presse Medicale

Volumn 36, Issue 6 II, 2007, Pages 979-984

  Mercadier, Jean Jacques ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE COURSE; HEART FAILURE; HEART INFARCTION; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE OVERLOAD; HYPERTENSION; MECHANICAL STRESS; PATHOPHYSIOLOGY; SHORT SURVEY; CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; HEART VENTRICLE REMODELING; HUMAN; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

CARDIOMYOPATHIES; HEART FAILURE, CONGESTIVE; HUMANS; SIGNAL TRANSDUCTION; VENTRICULAR REMODELING;

EID: 34249654125     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2007.02.022     Document Type: Short Survey

References (18)

1. Mercadier J.J. Insuffisance cardiaque : physiopathologie. Traité de cardiologie et de pathologie vasculaire. Société Française de Cardiologie (2007), Masson/Elsevier, Paris
2. Knoll R., Hoshijima M., Hoffman H.M., Person V., Lorenzen-Schmidt I., Bang M.L., et al. The cardiac mechanical stretch sensor machinery involves a Z disc complex that is defective in a subset of human dilated cardiomyopathy. Cell 111 (2002) 943-955
3. Grossman W., Jones D., and McLaurin L.P. Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest 56 (1975) 56-64
4. Alpert N.R., and Gordon M.S. Myofibrillar adenosine triphosphatase activity in congestive heart failure. Am J Physiol 202 (1962) 940-946
5. Suko J., Vogel J.H.K., and Chidsey C.A. Intracellular calcium and myocardial contractility - reduced calcium uptake and ATPase of the sarcoplasmic reticular fraction prepared from chronically failing calf hearts. Circ Res 27 (1970) 235-247
6. Frey N., and Olson E.N. Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol 65 (2003) 45-79
7. Dorn G.W., and Force T. Protein kinase cascades in the regulation of cardiac hypertrophy. J Clin Invest 115 (2005) 527-537
8. Mercadier J.J. Determinants of cardiac remodeling and progression to heart failure. In: Hosenpud J., and Greenberg B. (Eds). Congestive Heart Failure (2007), Lippincott Williams & Wilkins, Philadelphia
9. Sakata Y., Hoit B.D., Liggett S.B., Walsh R.A., and Dorn G.W. Decompensation of pressure overload hypertrophy in G alpha q-overexpressing mice. Circulation 97 (1998) 1488-1495
10. Hill J.A., Karimi M., Kutschke W., Davisson R.L., Zimmerman K., Wang Z., et al. Cardiac hypertrophy is not a required compensatory response to short-term pressure overload. Circulation 101 (2000) 2863-2869
11. Esposito G., Rapacciuolo A., Naga Prasad S.V., Takaoka H., Thomas S.A., Koch W.J., et al. Genetic alterations that inhibit in vivo pressure-overload hypertrophy prevent cardiac dysfunction despite increased wall stress. Circulation 105 (2002) 85-92
12. Wilkins B.J., Dai Y.S., Bueno O.F., Parsons S.A., Xu J., Plank D.M., et al. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy. Circ Res 94 (2004) 110-118 (Epub 2003 Dec 1)
13. Zhang R., Khoo M.S., Wu Y., Yang Y., Grueter C.E., Ni G., et al. Calmodulin kinase II inhibition protects against structural heart disease. Nat Med 11 (2005) 409-417
14. Kim Y.K., Kim S.J., Yatani A., Huang Y., Castelli G., Vatner D.E., et al. Mechanism of enhanced cardiac function in mice with hypertrophy induced by overexpression of Akt. J Biol Chem 278 (2003) 47622-47628
15. Hirota H., Chen J., Betz U.A., Rajewsky K., Gu Y., Ross J., et al. Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onser of heart failure during biomechanical stress. Cell 97 (1999) 189-198
16. Bers D.M. Beyond beta blockers. Nat Med 11 (2005) 379-380
17. Takimoto E., Champion H.C., Li M., Belardi D., Ren S., Rodriguez E.R., et al. Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy. Nat Med 11 (2005) 214-222
18. McKinsey T.A., and Olson E.N. Toward transcriptional therapies for the failing heart: chemical screens to modulate genes. J Clin Invest 115 (2005) 538-546